Peripartum cardiomyopathy is a life-threatening condition that requires urgent diagnosis and management. Bromocriptine was established as disease specific therapy; less data is known about Cabergolin which is another prolactin secretion inhibitor. In this paper we report 4 peripartum cardiomyopathy cases treated successfully with Cabergoline, including a cardiogenic shock case requiring mechanical circulatory support.
Keywords: Cabergoline; Cardiogenic shock; Cardiomyopathie du péripartum; Mechanical circulatory support; PPCM; VA ECMO; assistance circulatoire mécanique; chock cardiogénique.
Copyright © 2023 Elsevier Masson SAS. All rights reserved.